NCI: Cancer Information

Cancer Information Announcements

New NCI Network Formed to Increase Consumer Advocate Involvement
Dole Vice President Accepts Position as Director of NCI 5 A Day Program
Report of the Lung Cancer Progress Review Group
NCI Events at the American Society of Clinical Oncology (ASCO) Annual Meeting, May 12-15, 2001
How to Propose a New Extraordinary Opportunity for Investment
Request for Nominations to the Director's Consumer Liaison Group
Report of the Brain Tumor Progress Review Group
Cancer Clinical Trials: A New National System: a new feature on the cancerTrials website provides a gateway to many of NCI's new initiatives to increase clinical trial access to patients and physicians
Report on Carcinogens - 9th Edition
NCI Releases Strategic Plan to Reduce Health Disparities

CancerNet™ provides comprehensive information about cancer by covering topics such as:

cancerTrials is NCI's comprehensive clinical trials site, providing access to NCI's clinical trials database, news about cancer research, and resources for patients and health professionals about participating in clinical trials.

Cancer Information Service (CIS)
Provides the latest, most accurate cancer information. In the U.S., you can call the CIS between 9:00 a.m. and 4:30 p.m. local time, Monday through Friday at 1-800-4-CANCER (1-800-422-6237).

Information for the Public and the Media

Public

Awareness campaigns
Educational resources
Publications

Newscenter

Ethnic and Minority Health
The health and welfare of minority groups, ethnic populations, the elderly and the medically underserved are important issues to the NCI. The Office of Special Populations Research coordinates the Institutes efforts in this area.

Surveillance, Epidemiology & End Results (SEER)
The SEER Program is the most authoritative source of information on cancer incidence and survival in the U.S.

The Cancer Mortality Maps & Graphs
The Cancer Mortality Maps & Graphs Web Site provides interactive maps, graphs (which are accessible to the blind and visually-impaired), text, tables and figures showing geographic patterns and time trends of cancer death rates for the time period 1950-1994 for more than 40 cancers

Progress Review Groups
NCI undertakes a variety of efforts to assess and evaluate programs and projects within the Insititute's portfolio of supported research. The Progress Review Groups are charged with developing a national disease-specific research agenda to accelerate progress in cancer research.

The Office of Cancer Complementary and Alternative Medicine
OCCAM was established in October 1998 to coordinate and enhance the activities of the NCI in the arena of complementary and alternative medicine (CAM).